These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5614497)

  • 21. [Study of the regional circulation of arteriosclerosis patients during treatment with dextro-thyroxine].
    Furitano G; Salerno L; Cerasola GA; Custro N
    Boll Soc Ital Biol Sper; 1974 Aug; 50(16-2):1273-6. PubMed ID: 4458714
    [No Abstract]   [Full Text] [Related]  

  • 22. Dextrothyroxine for lowering serum cholesterol. Analysis of data on 6066 patients.
    Bechtol LD; Warner WL
    Angiology; 1969 Nov; 20(10):565-79. PubMed ID: 5347944
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sodium dextrothyrosine in the treatment of idiopathic hyperlipidemia coexistent with diabetes mellitus].
    Kaniak J; Knapik Z; Malus-Gronowska D
    Pol Tyg Lek; 1966 Oct; 21(41):1572-3. PubMed ID: 5980361
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W; Black D; Dujovne C; Hosking JD; Hunninghake D; Keilson L; Knopp R; McKenney J; Stein E; Troendle AJ
    Arch Intern Med; 1994 Nov; 154(21):2449-55. PubMed ID: 7979841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of sodium dextrothyroxine in hypercholesterolemic patients with angina pectoris].
    PADILLA T; PADILLA T; PADILLA MA; PADILLA LT
    Dia Med; 1962 Nov; 34():2318-20. PubMed ID: 13940999
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of sodium d-thyroxine on normal and hypercholesterolaemic males.
    ROPER BW
    Br J Clin Pract; 1963 Feb; 17():75-8. PubMed ID: 13974718
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of probucol in treating primary hypercholesterolemia.
    Enjalbert M; Lussier-Cacan S; DuBreuil-Quidoz S; LeLorier J; Davignon J
    Can Med Assoc J; 1980 Oct; 123(8):754-7. PubMed ID: 7448680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiatherogenic activity of cetaben sodium, sodium p-(hexadecylamino) benzoate, in the aortae of hypercholesteremic rabbits subjected to aortic endothelial cell desquamation.
    Katocs AS; Schaffer SA
    Artery; 1982; 11(3):192-206. PubMed ID: 6985202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The cholesterol-decreasing effect of atromid. A clinical study].
    Mogensen EF
    Ugeskr Laeger; 1965 Oct; 127(41):1290-3. PubMed ID: 5868038
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypercholesterolemia: when and how much to treat it?].
    Carmena R
    Med Clin (Barc); 1983 Feb; 80(6):261-2. PubMed ID: 6865558
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia].
    Pasquali R; Melchionda N; Parenti M; Cavazzini MG; Biso P; Baraldi G; Sorrenti G; De Benedittis G; Labò G
    Clin Ter; 1982 Dec; 103(5):509-20. PubMed ID: 7160143
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypolipidemic agents--newly approved.
    Duncan GG
    Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified D-thyroxine in athyreotic patients.
    Hamon P; Dingeon B; Jiang NS; Orgiazzi J
    Lancet; 1993 Jun; 341(8858):1477. PubMed ID: 8099168
    [No Abstract]   [Full Text] [Related]  

  • 36. [Probucol in the treatment of hypercholesterolemia].
    da Cunha GP; da Cunha CL
    Arq Bras Cardiol; 1981 Jul; 37(1):63-6. PubMed ID: 7348171
    [No Abstract]   [Full Text] [Related]  

  • 37. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pool size and turnover of bile acids in six hypercholesteremic patients with and without administration of nicotinic acid.
    Wollenweber J; Kottke BA; Owen CA
    J Lab Clin Med; 1967 Apr; 69(4):584-93. PubMed ID: 6020697
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypercholesterolemia--a clinical problem in heart transplantation. A therapeutic trial with low-dose lovastatin].
    Simonsen S; Gullestad L; Forfang K; Ihlen H; Nordal KP; Geiran O; Høstmark AT
    Tidsskr Nor Laegeforen; 1995 Jan; 115(3):357-9. PubMed ID: 7855835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.